Cold activation of complement i. presence of coagulation-related activator
- PMID: 59781
Cold activation of complement i. presence of coagulation-related activator
Abstract
Determination of the complement titer in the serum and plasm of 120 patients with chronic liver diseases showed that in eight (7%) patients with cirrhosis of the liver, chronic active or chronic inactive hepatitis complement in the serum was less than half in the plasma. The dissociation of complement serum and plasma was due to cold activation of the classical pathway of complement in vitro since serum drawn from these patients at 37 degrees C lost hemolytic activity in 4 hours when transferred to a cold environment. Neither HB antigen nor cryoglobulin participated in this phenomenon. The activation of complement in the cold could be prevented by increasing the ionic strength, or by adding vitamin E or, to a lesser extent its vehicle HCO-60, while heparin, Trasylol, soybean trypsin inhibitor, or hirudin had no effect. Trans-AMCHA prevented activation in one case. It is speculated that a factor appearing as a result of blood clotting is able to activate the classical pathway of complement in the cold; it is probably not related to Hageman factor (factor XII), factor VII, thrombin, kallikrein.
Similar articles
-
The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis.Clin Exp Immunol. 1977 Jan;27(1):34-7. Clin Exp Immunol. 1977. PMID: 849648 Free PMC article.
-
Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.J Lab Clin Med. 1984 Apr;103(4):560-73. J Lab Clin Med. 1984. PMID: 6366096
-
C-1 inactivator and cold-promoted activation of factor VII.J Lab Clin Med. 1978 Aug;92(2):152-63. J Lab Clin Med. 1978. PMID: 681808
-
Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.Clin Haematol. 1985 Jun;14(2):281-342. Clin Haematol. 1985. PMID: 2994929 Review.
-
Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.Pathobiol Annu. 1982;12:35-64. Pathobiol Annu. 1982. PMID: 6186978 Review. No abstract available.
Cited by
-
Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.Gastroenterol Jpn. 1981;16(2):174-85. doi: 10.1007/BF02774392. Gastroenterol Jpn. 1981. PMID: 6971771
-
A case of Menetrier's disease associated with protein-losing gastropathy and abnormal serum complement profile.Gastroenterol Jpn. 1978;13(4):297-302. doi: 10.1007/BF02774053. Gastroenterol Jpn. 1978. PMID: 710825
-
Relationships among the complement, kinin, coagulation, and fibrinolytic systems.Springer Semin Immunopathol. 1983;6(2-3):231-58. doi: 10.1007/BF00205875. Springer Semin Immunopathol. 1983. PMID: 6227099 Review. No abstract available.
-
The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin.Clin Exp Immunol. 1995 Aug;101(2):284-7. doi: 10.1111/j.1365-2249.1995.tb08352.x. Clin Exp Immunol. 1995. PMID: 7648711 Free PMC article.
-
Cold-dependent activation of complement: recognition, assessment, and mechanism.J Clin Immunol. 1992 Sep;12(5):362-70. doi: 10.1007/BF00920794. J Clin Immunol. 1992. PMID: 1430107